NLRP6 suppresses the inflammatory response of human periodontal ligament cells by inhibiting NF-κB and ERK signal pathways
NLRP6 suppresses the inflammatory response of human periodontal ligament cells by inhibiting NF-κB and ERK signal pathways
复制标题
NLRP6通过抑制NF-κB和ERK信号通路抑制人牙周膜细胞的炎症反应
DOI:
10.1111/iej.13091
复制
发表时间:
2019-07-01
影响因子:
5
通讯作者:
Huang, D. M.
中科院分区:
文献类型:
--
作者:
Lu, W. L.;Zhang, L.;Huang, D. M.
Aim To explore the function and mechanisms of NLRP6 (NOD-, LRR- and pyrin domain-containing 6) in the inflammatory response of human periodontal ligament cells (HPDLCs). Methodology Tissues associated with apical periodontitis were obtained from three patients who underwent endodontic microsurgery. The expression of NLRP6 in 3 human apical periodontitis tissues and HPDLCs was examined by immunohistochemistry and immunofluorescence, respectively. The expressions of NLRP6, Phospho(p)- p65, p65, I kappa B-alpha, p- I kappa B-alpha, ERK, p- ERK, NLRP3, Pro interleukin (IL)-1 beta, Pro caspase-1 and apoptosis-associated speck-like protein containing a CARD (ASC) were examined by western blot. The gene expression and secretion of proinflammatory cytokines were detected using quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay. Data were analysed statistically with independent sample t-tests. Results NLRP6 was expressed in inflammatory periapical tissues and HPDLCs. Lipopolysaccharide (LPS) from Escherichia coli induced NLRP6 in HPDLCs (P < 0.05). After silencing NLRP6, E. coli LPS-induced activation of NF-kappa B and ERK signalling was enhanced, which was also accompanied by elevated levels of IL-6 and tumour necrosis factor-alpha (TNF-alpha) (P < 0.05). Moreover, knockdown of NLRP6 led to up-regulation of NLRP3, Pro IL-1 beta and Pro caspase-1 (P < 0.05), whereas down-regulation of ASC (P < 0.05), which may contribute to unchanged levels of IL-1 beta in HPDLCs inflammation. Conclusion NLRP6 was functionally expressed in inflamed periapical tissues and HPDLCs. NLRP6 negatively regulated the production of IL-6 and TNF-alpha in HPDLCs inflammation by inhibiting NF-kappa B and ERK signal pathways.